CARDIFF ONCOLOGY Trademark

Trademark Overview

On Wednesday, February 19, 2020, a trademark application was filed for CARDIFF ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the CARDIFF ONCOLOGY trademark a serial number of 88803385. The federal status of this trademark filing is REGISTERED as of Tuesday, July 27, 2021. This trademark is owned by Trovagene, Inc.. The CARDIFF ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical research and development
cardiff oncology

General Information

Serial Number88803385
Word MarkCARDIFF ONCOLOGY
Filing DateWednesday, February 19, 2020
Status700 - REGISTERED
Status DateTuesday, July 27, 2021
Registration Number6431028
Registration DateTuesday, July 27, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"CARDIFF ONCOLOGY"
Description of MarkThe mark consists of the phrase "Cardiff Oncology" in a stylized font, to the left of which are three different sized hexagons.
Goods and ServicesPharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 24, 2020
Primary Code042
First Use Anywhere DateMonday, April 13, 2020
First Use In Commerce DateMonday, April 13, 2020

Trademark Owner History

Party NameCARDIFF ONCOLOGY, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameCARDIFF ONCOLOGY, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameCARDIFF ONCOLOGY, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameTrovagene, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, July 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 6, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, April 6, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 6, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, April 6, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 6, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, April 5, 2021USE AMENDMENT ACCEPTED
Saturday, April 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 2, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, April 3, 2021AMENDMENT TO USE PROCESSING COMPLETE
Saturday, April 3, 2021USE AMENDMENT FILED
Friday, April 2, 2021TEAS AMENDMENT OF USE RECEIVED
Wednesday, March 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 27, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, November 27, 2020FINAL REFUSAL E-MAILED
Friday, November 27, 2020FINAL REFUSAL WRITTEN
Tuesday, November 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 9, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, May 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 14, 2020NON-FINAL ACTION E-MAILED
Thursday, May 14, 2020NON-FINAL ACTION WRITTEN
Thursday, May 7, 2020ASSIGNED TO EXAMINER
Tuesday, February 25, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 22, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

oncology cardiff research development pharmaceutical treatment cancer field diagnosis medical scientific pharmaceuticals